» Authors » Tangwei Wu

Tangwei Wu

Explore the profile of Tangwei Wu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 480
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Li Y, Hu H, Wu Z, Yan G, Wu T, Liu S, et al.
Biosci Rep . 2020 Feb; 40(2). PMID: 32068231
Objectives: The post-imaging, mathematical predictive model was established by combining demographic and imaging characteristics with a pulmonary nodule risk score. The prediction model provides directions for the treatment of pulmonary...
12.
Zhu M, Tan Z, Luo Z, Hu H, Wu T, Fang S, et al.
Biosci Rep . 2019 Aug; 39(9). PMID: 31467173
Nowadays, vitamin D is known to have functions beyond bone formation, including inhibiting angiogenesis and promoting tumor apoptosis. CYP27B1 and group-specific component (GC), the main enzyme responsible for the degradation...
13.
Wang H, Tan Z, Hu H, Liu H, Wu T, Zheng C, et al.
BMC Cancer . 2019 Jul; 19(1):738. PMID: 31351450
Background: Breast cancer is the most common cancer type in female. As microRNAs play vital role in breast cancer, this study aimed to explore the molecular mechanism and clinical value...
14.
Wu T, Hu H, Zhang T, Jiang L, Li X, Liu S, et al.
Oxid Med Cell Longev . 2019 Jul; 2019:9719723. PMID: 31316723
Metastasis is the leading cause of high mortality in lung cancer patients, and metastatic lung cancer is difficult to treat. miRNAs are involved in various biological processes of cancer, including...
15.
Hu H, Zhang Q, Chen W, Wu T, Liu S, Li X, et al.
Carcinogenesis . 2019 Jun; 41(4):502-514. PMID: 31233116
Pancreatic cancer is one of the most lethal digestive malignant tumors. We had previously found that microRNA-301a (miR-301a) is a oncogenic microRNA whose recognized conduce to nuclear factor-kappa B (NF-κB)...
16.
Zhang T, Hu H, Yan G, Wu T, Liu S, Chen W, et al.
Technol Cancer Res Treat . 2019 Apr; 18:1533033819843889. PMID: 30983509
Breast cancer, one of the most common diseases among women, is regarded as a heterogeneous and complicated disease that remains a major public health concern. Recently, owing to the development...
17.
Li X, Kong D, Chen H, Liu S, Hu H, Wu T, et al.
Sci Rep . 2016 Feb; 6:21789. PMID: 26899994
Atherosclerosis (AS) is chronic inflammation in response to lipid accumulation. MicroRNA-155 (miR-155) is being increasingly studied to evaluate its potential as diagnostic biomarkers and therapeutic targets in many diseases. However,...
18.
Wu T, Chen W, Kong D, Li X, Lu H, Liu S, et al.
Carcinogenesis . 2015 May; 36(8):925-35. PMID: 25998847
To determine the role of miR-25 in non-small cell lung cancer (NSCLC), we first detected miR-25 expression in clinical specimens and lung cancer cell lines by quantitative real-time polymerase chain...
19.
Wu T, Chen W, Liu S, Lu H, Wang H, Kong D, et al.
FEBS Lett . 2014 May; 588(12):2107-14. PMID: 24815696
Various studies have reported that Huaier possesses anti-tumor effects. However, the mechanisms are not completely elucidated. Here, we found 66 differentially expressed miRNAs in Huaier-treated pulmonary adenocarcinoma A549 cells, with...
20.
Kong D, Chen H, Chen W, Liu S, Wang H, Wu T, et al.
Eur J Med Res . 2013 Nov; 18:44. PMID: 24229431
Background: Primary hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. However, the molecular pathogenesis of HCC is not well-understood, and the prognosis for patients with...